NO20050366L - Depotformuleringer med kort varighet - Google Patents

Depotformuleringer med kort varighet

Info

Publication number
NO20050366L
NO20050366L NO20050366A NO20050366A NO20050366L NO 20050366 L NO20050366 L NO 20050366L NO 20050366 A NO20050366 A NO 20050366A NO 20050366 A NO20050366 A NO 20050366A NO 20050366 L NO20050366 L NO 20050366L
Authority
NO
Norway
Prior art keywords
short
polymer
beneficial agent
term deposit
deposit formulations
Prior art date
Application number
NO20050366A
Other languages
English (en)
Norwegian (no)
Inventor
Guohua Chen
David Priebe
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20050366L publication Critical patent/NO20050366L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B18/00—Use of agglomerated or waste materials or refuse as fillers for mortars, concrete or artificial stone; Treatment of agglomerated or waste materials or refuse, specially adapted to enhance their filling properties in mortars, concrete or artificial stone
    • C04B18/04—Waste materials; Refuse
    • C04B18/18—Waste materials; Refuse organic
    • C04B18/20—Waste materials; Refuse organic from macromolecular compounds
    • C04B18/22—Rubber, e.g. ground waste tires
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B28/00—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
    • C04B28/02—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing hydraulic cements other than calcium sulfates
    • C04B28/04—Portland cements
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/40—Porous or lightweight materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W30/00—Technologies for solid waste management
    • Y02W30/50—Reuse, recycling or recovery technologies
    • Y02W30/91—Use of waste materials as fillers for mortars or concrete

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ceramic Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Civil Engineering (AREA)
  • Environmental & Geological Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20050366A 2002-06-25 2005-01-24 Depotformuleringer med kort varighet NO20050366L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39186702P 2002-06-25 2002-06-25
PCT/US2003/019762 WO2004000269A1 (en) 2002-06-25 2003-06-25 Short duration depot formulations

Publications (1)

Publication Number Publication Date
NO20050366L true NO20050366L (no) 2005-03-23

Family

ID=30000765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050366A NO20050366L (no) 2002-06-25 2005-01-24 Depotformuleringer med kort varighet

Country Status (19)

Country Link
EP (3) EP2316421A1 (pl)
JP (2) JP2005533081A (pl)
KR (1) KR101172721B1 (pl)
CN (1) CN1671357B (pl)
AR (1) AR039729A1 (pl)
AU (1) AU2003245643B2 (pl)
BR (1) BR0312033A (pl)
EC (1) ECSP055566A (pl)
ES (1) ES2530874T3 (pl)
IL (1) IL165865A0 (pl)
MA (1) MA27371A1 (pl)
MX (1) MXPA05000199A (pl)
NO (1) NO20050366L (pl)
NZ (1) NZ574443A (pl)
PL (1) PL207147B1 (pl)
RU (1) RU2320321C2 (pl)
TW (1) TWI353854B (pl)
WO (1) WO2004000269A1 (pl)
ZA (1) ZA200500677B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US7368126B2 (en) 2002-11-06 2008-05-06 Guohua Chen Controlled release depot formulations
US20050106214A1 (en) * 2003-11-14 2005-05-19 Guohua Chen Excipients in drug delivery vehicles
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
US8658210B2 (en) 2006-04-17 2014-02-25 Advanced Cardiovascular Systems, Inc. Polyesteramide platform for site specific drug delivery
WO2008143992A2 (en) 2007-05-18 2008-11-27 Durect Corporation Improved depot formulations
MX354603B (es) 2007-05-25 2018-03-13 Indivior Uk Ltd Formulaciones de transferencia sostenida de compuestos de risperidona.
US8846068B2 (en) * 2008-04-18 2014-09-30 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising a local anesthetic
CA2838289C (en) * 2011-06-10 2019-09-10 Ramscor, Inc. Sustained release formulations for delivery of proteins to the eye and methods of preparing same
CN115804749A (zh) 2013-03-11 2023-03-17 度瑞公司 包含高粘度液体载体的可注射控制释放组合物
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CN111388406B (zh) * 2020-03-24 2024-02-23 西安力邦医药科技有限责任公司 氟维司群或其衍生物可注射递药贮库及其制备方法和应用
EP4277702A1 (en) 2021-01-12 2023-11-22 Durect Corporation Sustained release drug delivery systems and related methods

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797492A (en) 1972-12-27 1974-03-19 Alza Corp Device for dispensing product with directional guidance member
US3987790A (en) 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4443340A (en) 1981-10-09 1984-04-17 Betz Laboratories, Inc. Control of iron induced fouling in water systems
US4985404A (en) 1984-10-04 1991-01-15 Monsanto Company Prolonged release of biologically active polypeptides
US4865845A (en) 1986-03-21 1989-09-12 Alza Corporation Release rate adjustment of osmotic or diffusional delivery devices
US4853218A (en) 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5085866A (en) 1988-12-02 1992-02-04 Southern Research Institute Method of producing zero-order controlled-released devices
US5059423A (en) 1988-12-13 1991-10-22 Alza Corporation Delivery system comprising biocompatible beneficial agent formulation
US5057318A (en) 1988-12-13 1991-10-15 Alza Corporation Delivery system for beneficial agent over a broad range of rates
US5324519A (en) 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5112614A (en) 1989-09-14 1992-05-12 Alza Corporation Implantable delivery dispenser
US5234693A (en) 1990-07-11 1993-08-10 Alza Corporation Delivery device with a protective sleeve
US5234692A (en) 1990-07-11 1993-08-10 Alza Corporation Delivery device with a protective sleeve
US5151093A (en) 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
US5620700A (en) 1990-10-30 1997-04-15 Alza Corporation Injectable drug delivery system and method
GB9027422D0 (en) 1990-12-18 1991-02-06 Scras Osmotically driven infusion device
US5137727A (en) 1991-06-12 1992-08-11 Alza Corporation Delivery device providing beneficial agent stability
US5288214A (en) 1991-09-30 1994-02-22 Toshio Fukuda Micropump
EP0572675B1 (en) 1991-12-19 1999-09-22 Mitsui Chemicals, Inc. Polyhydroxy carboxylic acid and production thereof
SK279964B6 (sk) * 1991-12-27 1999-06-11 Merck & Co. Dávkovacia forma na riadené uvoľňovanie liečiva a
US5209746A (en) 1992-02-18 1993-05-11 Alza Corporation Osmotically driven delivery devices with pulsatile effect
US5456679A (en) 1992-02-18 1995-10-10 Alza Corporation Delivery devices with pulsatile effect
US5308348A (en) 1992-02-18 1994-05-03 Alza Corporation Delivery devices with pulsatile effect
US5656297A (en) 1992-03-12 1997-08-12 Alkermes Controlled Therapeutics, Incorporated Modulated release from biocompatible polymers
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
US5242910A (en) 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
JPH08503950A (ja) 1992-12-02 1996-04-30 アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド 徐放性成長ホルモン含有マイクロスフェア
US5556905A (en) 1994-03-30 1996-09-17 Reilly Industries, Inc. Physically-modified degradable thermoplastic compositions
DE69534780T2 (de) 1994-04-08 2006-10-05 Qlt Usa Inc., Fort Collins Flüssige Zusammensetzungen zur Arzneistoffabgabe
US5626862A (en) 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
WO1998027963A2 (en) * 1996-12-20 1998-07-02 Alza Corporation Gel composition and methods
US6841617B2 (en) * 2000-09-28 2005-01-11 Battelle Memorial Institute Thermogelling biodegradable aqueous polymer solution
AU779277B2 (en) * 1999-06-04 2005-01-13 Alza Corporation Implantable gel compositions and method of manufacture
CA2401340A1 (en) * 2000-02-28 2001-09-07 The University Of British Columbia Compositions and methods for the treatment of inflammatory disease using topoisomerase inhibitors
WO2002000137A1 (en) * 2000-06-28 2002-01-03 Shukla Atul J Biodegradable vehicles and delivery systems of biologically active substances
US7194507B2 (en) * 2000-06-29 2007-03-20 Ntt Docomo, Inc. Method and apparatus for setting communication parameter in information terminal
AU2002226000A1 (en) 2000-11-13 2002-05-21 Atrix Laboratories, Inc. Injectable sustained release delivery system with loperamide
DK1372729T3 (da) * 2001-02-23 2009-06-22 Genentech Inc Nedbrydelige polymere til injektion
US7829109B2 (en) * 2001-11-14 2010-11-09 Durect Corporation Catheter injectable depot compositions and uses thereof
KR20040058100A (ko) * 2001-11-14 2004-07-03 알자 코포레이션 주입가능한 데포 조성물 및 그의 용도

Also Published As

Publication number Publication date
ZA200500677B (en) 2006-08-30
ECSP055566A (es) 2005-04-18
KR101172721B1 (ko) 2012-08-30
NZ574443A (en) 2010-08-27
AR039729A1 (es) 2005-03-09
RU2320321C2 (ru) 2008-03-27
JP2005533081A (ja) 2005-11-04
CA2492047C (en) 2014-08-12
EP2316421A1 (en) 2011-05-04
CN1671357A (zh) 2005-09-21
TW200404578A (en) 2004-04-01
KR20050026414A (ko) 2005-03-15
CN1671357B (zh) 2010-08-11
PL207147B1 (pl) 2010-11-30
EP1515697B1 (en) 2014-11-19
ES2530874T3 (es) 2015-03-06
WO2004000269A1 (en) 2003-12-31
IL165865A0 (en) 2006-01-15
BR0312033A (pt) 2005-04-26
EP1515697A1 (en) 2005-03-23
AU2003245643A1 (en) 2004-01-06
JP5631708B2 (ja) 2014-11-26
MXPA05000199A (es) 2005-06-06
JP2011068670A (ja) 2011-04-07
HK1082412A1 (en) 2006-06-09
RU2005101640A (ru) 2005-08-10
EP2311431A1 (en) 2011-04-20
MA27371A1 (fr) 2005-06-01
CA2492047A1 (en) 2003-12-31
TWI353854B (en) 2011-12-11
AU2003245643B2 (en) 2009-02-26
PL373123A1 (pl) 2005-08-08

Similar Documents

Publication Publication Date Title
NO20050366L (no) Depotformuleringer med kort varighet
BRPI0410953A (pt) composições de depósito elastoméricas que podem ser implantadas, usos das mesmas e processo de produção
NO20073529L (no) Preparater og fremgangsmater for behandling av tilstander i negleenheten
WO2006078282A3 (en) Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
WO2008054772A3 (en) Implantable elastomeric caprolactone depot compositions and uses thereof
WO2018212792A3 (en) BIOPOLYMER COMPOSITIONS, SCAFFOLDING AND DEVICES
WO2005120462A3 (en) Biodegradable and biocompatible crosslinked polymer hydrogel prepared from pva and/or peg macromer mixtures
PT1061900E (pt) Composicoes e metodos para libertacao de uma droga
MX2010001219A (es) Composiciones de acido hialuronico ajustablemente reticuladas.
UY28067A1 (es) Formulaciones de deposito de liberacion controlada
WO2009081408A3 (en) Pulverized fibrin clots and pharmaceutical compositions containing them
AU4972599A (en) Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
WO2006060235A3 (en) Bioabsorbable, biobeneficial, tyrosine-based polymers for use in drug eluting stent coatings
NO20065652L (no) Fremgangsmate for fremstilling av formede gjenstander pa basis av tverrbundet gelatin
DE602005018178D1 (de) Phospholipid und verunreinigungsbeständige beschichtungszusammensetzungen
WO2009100280A3 (en) 3-dimensional silk hydroxyapatite compositions
NO20056060L (no) Polyetylenoksidbaserte filmer og legemiddelleveringssystemer fremstilt fra disse
DE602004005727D1 (de) Reaktive hydrophile oligomere
WO2006034128A8 (en) Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
ATE284698T1 (de) Aktivierung natürlicher killerzellen durch adenosin-a3-rezeptoragonisten
BRPI0607483A2 (pt) microimplantes para administração ocular
WO2004004598A3 (en) Polymerized and modified rapamycins and their use in coating medical prostheses
AR045016A1 (es) Derivados de 5-carbamimidoi-2-metilsulfaniltiofen-3-sulfonil como inhibidores conjugados de la cascada de complemento y su uso en el tratamiento de enfermedades.
WO2008021548A3 (en) Epoxy-containing poly(ester amides) and methods of use
WO2007139760A3 (en) Resorbable polymer compositions for use in medicine, dentistry, and surgery

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application